Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021
Describes a surveillance network of seven clinical sites focused on the use of medication for opioid use disorder (MOUD) during pregnancy. Initial report is limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status, including data for urban and rural areas.
Kathryn Miele, Shin Y. Kim, Rachelle Jones, et al.
MMWR Surveillance Summaries, 72(3), 1-14
Centers for Disease Control and Prevention
Illicit drug use · Pharmacy and prescription drugs · Prescription drug misuse · Rural-urban differences · Statistics and data